Method of preparing nanoparticle compositions containing charged phospholipids to reduce aggregation
AssigneeEastman Kodak Company
InventorsGeorge C. Na, Natarajan Rajagopalan
Life of this patent
Estimating the term…
Loading patent…
AssigneeEastman Kodak Company
InventorsGeorge C. Na, Natarajan Rajagopalan
Estimating the term…
This invention discloses a composition comprised of nanoparticles having a non-ionic surfactant as a surface modifier adsorbed on the surface thereof and a charged phospholipid as a cloud point modifier associated therewith, which cloud point modifier is present in an amount sufficient to increase the cloud point of the surface modifier. A preferred non-ionic surfactant surface modifier is a poloxamine or tyloxapol, and preferred charged phospholipid cloud point modifiers include dimyristoyl phosphatidyl glycerol. This invention further discloses a method of making nanoparticles having a non-ionic surfactant as a surface modifier adsorbed on the surface and a charged phospholipid as a cloud point modifier associated therewith, comprised of contacting said nanoparticles with the cloud point modifier for a time and under conditions sufficient to increase the cloud point of the surface modifier.
A method of making a sterilized composition comprised of nanoparticles which do not agglomerate during sterilization, wherein the nanoparticles are comprised of a therapeutic or diagnostic agent having 0.1 to 90% by weight of said nanoparticles of a non-ionic surfactant as a surface modifier adsorbed on the surface of said therapeutic or diagnostic agent, said nanoparticles having from 0.005 to 20% by weight of said composition of a charged phospholipid as a cloud point modifier on the surface of said nanoparticles, said method comprised of contacting said nanoparticles having said non-ionic surfactant adsorbed thereon with a solution of the cloud point modifier and said sterilization is performed by stream heat autoclaving.
Dependencies are inferred from the claim text.